Intrathecal Pumps Market - Global Industry Analysis, Size and Growth, 2023

Intrathecal pumps are widely used in the treatment of patients suffering from chronic pain without any/minimal side-effects. Economic factors such as, U.S. health insurance policies have boosted the demand of the intrathecal pumps market. Moreover, with advancing technology of the intrathecal pumps, the feasibility and flexibility of these devices have also grown with the current diagnostic methods, which in-turn is driving the intrathecal pumps market. Drugs such as Baclofen and Trihexy-phenidyl, which are used for the treatment of neuro-degeneration with brain iron accumulation and dystonia are not available in oral form, and hence, the demand of technically advanced intrathecal pumps with ability to perform multiple medications via single infusion pump has increased in recent years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/intrathecal-pumps-market/report-sample

Intrathecal pumps are used extensively for the injecting specific drugs to cancer patients. According to a report published by the International Agency for Research on Cancer (IARC of WHO), the number of cancer patients has been considerably increased. About 14.1 million patients were estimated to suffer from cancer in 2012. Also, the cancer mortality rate was estimated to be about 8.2 million in the year 2012. With increasing prevalence of cancer, the intrathecal pumps market is expected to escalate in future.

Based on the various drug types, the global intrathecal pumps market can be broadly categorized as Baclofen, Hydromorphone, Morphine, Clonidine, Midazolam, Bupivacaine and others. Based on the different application of intrathecal pumps, the global intrathecal pumps market can be broadly classified into spasticity and pain management. Pain management occupied the maximum intrathecal pumps market’s share in 2014.

Explore more about “Global Intrathecal Pumps Market” at: https://www.psmarketresearch.com/market-analysis/intrathecal-pumps-market

Recently Flowonix Medical Inc., has launched a ‘Prometra’ intrathecal pump, featuring accurate drug delivery mechanism, dual-gated valve drug delivery and increased device longevity. Rising merger and accusation (M&A) activity and market consolidation in the global intrathecal pump market is expected to drive the intrathecal pump market during the forecast period.

Some of the major players operating in the global intrathecal pumps market include- Arrow International Medallion Therapeutics Inc., Codman & Shurtleff, Inc., Medtronic, Inc., and Flowonix, Inc., Tricumed GmbH among others.

In-Vitro Diagnostic (IVD) Market Trends, Size, Analysis and Overview, 2023

The global in-vitro diagnostic (IVD) market is growing significantly due to innovative condition specific markers for advance genomic and proteomic services in the industry. Massive unexplored market in in-vitro diagnostic industry of developing economies are creating ample opportunities for the in vitro diagnostic market to grow at a considerable rate in the coming years. The advanced research and development facilities in molecular diagnosis, new product developments and increasing investments by the companies are further accelerating the demand of in-vitro diagnostic in the industry. In addition, innovative launch of various techniques, having application in multiple therapeutic areas, are supporting the growth of in vitro diagnostic market in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/in-vitro-diagnostic-market/report-sample

In-vitro diagnostic are the tests performed outside the human body in an artificial environment. Demand for in-vitro diagnosis is increasing due to increasing prevalence of chronic diseases. According to Centre for Disease Control and Prevention, in 2012, approximately 117 million people had some of the chronic diseases in the U.S. In order to diagnose various conditions, such as infectious disease, sexually transmitted diseases, oncology, chronic diseases, and genetic testing, the number of diagnostic tests are increasing.

The in-vitro diagnostic market is categorized on the basis of technology, products and services, application and end users. On the basis of products and services of in-vitro diagnostic, the market is categorized as reagents and kits, instruments, data management software/hardware and services. On the basis of technology, the market is categorized as clinical chemistry, immunochemistry, microbiology, coagulation and hemostasis, hematology, molecular diagnostics, and others. Moreover, applications of in-vitro diagnosis are further categorized as diabetes, autoimmune disease, cardiology, infectious disease, oncology, nephrology, drug testing, HIV, and others.

Explore more about In-Vitro Diagnostic (IVD) Market: https://www.psmarketresearch.com/market-analysis/in-vitro-diagnostic-market

Some of the companies operating in the in-vitro diagnostic market are Roche Diagnostics, Abbott Laboratories, Ortho Clinical Diagnostics, Inc., Biomerieux, Thermo Fisher Scientific, Inc., Siemens Healthcare, Johnson & Johnson, Becton Dickinson and Company, Danaher Corporation, Sysmex Corporation, and Bio-Rad Laboratories, Inc.

Microscopy Devices Market - Industry Analysis, Size, Growth and Demand, 2023

The global microscopy devices market is growing significantly due to increasing research and innovation in the field of life sciences and nanotechnology. Massive unexplored market in microscopy industry of developing economies and introduction of niche applications area such as quantum dots, and miniature transistor chips are creating ample opportunities for the microscopy devices market to grow at a considerable rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/microscopy-devices-market/report-sample

Microscopes have facilitated researches to conduct exhaustive academic and exploratory research, in order to deliver potential innovations in the field of lifesciences, such as clinical/ pathology and cell biology. Nanotechnology and other accuracy manufacturing industries, such as medical devices and semiconductors manufacturing, increases the acceptance rate of the advanced microscopes, which further supports the growth of microscopy devices market considerably. Moreover, increasing number of semiconductor manufacturing establishments is also supporting the growth of the microscopy devices market.

On the basis of type of devices, the global microscopy devices market is categorized as optical microscope, electron microscopes, and scanning probe microscopes. The optical microscope is further categorized as stereomicroscope, inverted microscope, near-field scanning microscope, fluorescence microscopes, confocal scanning microscope, phase contrast microscope and others. The electron microscope is further categorized as scanning electron microscope and transmission electron microscope. The scanning probe microscope includes atomic force microscope, and scanning tunneling microscope. Based on type of devices, the optical microscopes leads the microscopy devices market, as it is the oldest type of microscope and it is used mostly by researchers in the public, and private research laboratories and academic institutes. Optical microscopes dominate the market due to its ease to use with minimal sample preparations and it is cost effective.

Explore Report at: https://www.psmarketresearch.com/market-analysis/microscopy-devices-market

Geographically, North America will be the leading global electron microscope and scanning probe microscopes market due to technologically advancement and increased research and development in nanotechnology and lifesciences in the region. In addition, the supporting infrastructure and affordability for electron microscope supports the growth of electron microscope in North America. Asia-Pacific is expected to be the fastest growing region in the global microscopy devices market in the coming years. The major reasons for the fastest growth of the market in the region are growing government initiatives and investment in the research and development. Moreover, the microscopy devices market is growing due to presence of various schools, universities and research institutions, which would translate to greater growth in the coming years, in the emerging countries such as India and China of Asia-Pacific region.

Browse related market research: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the companies operating in the microscopy devices market are FEI Company, Carl Zeiss AG, Bruker Corporation, Danish Micro Engineering A/S, Cameca SAS, Leica Microsystems, NT-MDT Company, JEOL Ltd., Hitachi High Technologies Corporation, Nikon Corporation, and Olympus Corporation.

Breast Imaging Technologies Market - Global Industry Analysis, Trends, Growth and Demand, 2023

The global breast imaging technologies market is growing significantly due to technological advancement in the detection of breast cancer in the industry. Massive unexplored market in breast imaging technologies industry of developing economies are creating ample opportunities for the breast imaging technologies market to grow at a considerable rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/breast-imaging-technologies-market/report-sample

The advanced research and development facilities and new product developments by the companies are supporting to address the demand for the breast imaging technologies industry. However, strict regulatory approval procedures, and unfavorable reimbursement policies in the developing countries are posing a challenge for the growth of the breast imaging technologies market.

Breast cancer is the most common cancer in women. According to International Agency for Research on Cancer (IARC) and World Health Organization (WHO), globally, approximately 1.7 million new cases of breast cancer were diagnosed in 2012. As the incidence of breast cancer is increasing significantly, development of improved technology with less radiation exposure is also expected to support the growth of the breast imaging technologies market.

Explore more about Breast Imaging Technologies Market: https://www.psmarketresearch.com/market-analysis/breast-imaging-technologies-market

On the basis of devices technology, the breast imaging technologies market is categorized as ionizing breast imaging technologies and non-ionizing breast imaging technologies. Ionizing breast imaging technologies are further categorized as analog mammography, 3D breast tomosynthesis, positron emission tomography, and others. Non-ionizing breast imaging technologies devices market is further categorized as breast magnetic resonance imaging, breast ultrasound, breast theromography, and others. Ionizing breast imaging technologies dominates the global breast imaging technologies market; whereas, non-ionizing breast imaging technologies is the fastest growing product category of breast imaging technologies market, due to increasing need for lower dose of radiation exposure.

Some of the companies operating in the breast imaging technologies market are Toshiba Corporation, Aurora Imaging Technologies, Dilon Technologies, Inc., Gamma Medica, Inc., Sonocine, Inc., Siemens Healthcare, Philips Healthcare, GE Healthcare, Dune Medical Devices, U-Systems, Inc., and Hologic, Inc.

Operating Room Equipment Market Size, Drivers, Trends, Challenges & Forecast

The global operating room equipment market is growing substantially due to increasing investment in research and development for the expansion of technologically advanced equipment, rapid transformation from conventional to hybrid operating rooms and growing medical tourism in emerging economies. Massive unexplored market in operating room equipment industry of developing economies are creating ample opportunities for the operating room equipment market to grow at a considerable rate in coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/operating-room-equipment-market/report-sample

The advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the operating room equipment industry. Operating rooms are exclusively tailored rooms in a hospital to execute surgical operations and boost better patient care. In addition, technologically advanced equipment enhances operational efficiency by endowing healthcare professionals and surgeons. It comprises of especially designed equipment, such as operating tables, operating room lights, high resolution and high definition surgical imaging displays, and surgical booms.

On the basis of product type, the market can be categorized as operating room lights, surgical imaging displays, surgical booms, operating tables, and operating room integration systems. Operating tables leads the market in terms of market size; whereas, the operating room integration systems and operating booms are expected to be the two fastest growing segments in the coming years due to increasing demand for hybrid operating rooms, which require these equipment for proper equipment integration and space management. Operating tables are further segmented on the basis of types as standard operating table and specialty operating tables. Specialty operating tables are expected to grow at the faster rate during the forecast period due to increasing demand for specialty operating tables.

Explore Report at: https://www.psmarketresearch.com/market-analysis/operating-room-equipment-market

Some of the companies operating in the global operating room equipment market are Karl Stroz GmbH & Co. KG, Berchtold Corporation, NDS Surgical Imaging, LLC, TRUMPF GmbH & CO. KG, Skytron, LLC, Steris Corporation, Getinge Group, Mizuho OSI, Eschmann Equipment, and Stryker Corporation.

Bolus Injectors Contribute Largest Revenue to Global Wearable Injectors Market

The global wearable injectors market is likely to grow from $2,162.1 million in 2015 to $13.0 billion by 2024. With the explosive growth of bolus injectors and increasing interest of pharmaceutical companies in collaborating with device manufacturers for drug device combination, the market for wearable injectors is expected to show dramatic rise. The launch of bolus injector expands the usage of wearable injectors from diabetes to other disease segments, as the wearable injectors currently available in market are majorly insulin pumps. The growing need for continuous and subcutaneous drug delivery has developed the demand for wearable injectors among the patients.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/wearable-injectors-market/report-sample

Cancer is expected to be the largest application area of wearable injectors. According to the analyst, cancer and autoimmune disease are expected to be the major application areas for wearable injectors in the near future. The other key applications of wearable injectors include infectious disease, cardiovascular disease and blood disorders. Also, homecare is expected to be the largest end user of wearable injectors.

Growing need for advanced drug delivery is one of the major factors driving the growth of the global wearable injectors market. Increasing demand for homecare and advanced drug delivery requiring minimal expertise and lesser hospitalization of patients is expected to drive the demand for wearable injectors, globally. Also, many biopharmaceutical companies have been looking for a better mode of drug delivery for their portfolio of biologic drugs, for which wearable injectors are an appropriate solution.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/wearable-injectors-market

Increasing need for better patient care is creating ample growth opportunities for the global market. Electronic wearable injectors create yet another opportunity for the global market, as these types of wearable injectors are technically more advanced, do not require patient training and are easy to use. As compared to these, mechanical wearable injectors are self-administration devices that require one time administration of the drugs, manually, by the patient. Mechanical wearable injectors are either pre-loaded or loaded at the time of administration.

The research states that the global wearable injectors market had a consolidated structure in 2015, where the top three competitors accounted for the major share in the global wearable injectors market. Some of the key players operating in the global market are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, CeQur SA, Enable Injections, ScPharmaceuticals, Inc., SteadyMed Ltd., Ypsomed Group, West Pharmaceutical Services, Inc. and Canè S.p.A.

Weight Management Market Size, Share, Growth and Forecast to 2023

The global weight management market is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.

Explore more or request TOC on “Global Weight Management Market” at: https://www.psmarketresearch.com/market-analysis/weight-management-market

Massive unexplored market in weight management industry and increasing medical tourism in developing economies are creating ample opportunities for the weight management market to grow at a considerable rate during the forecasted period. In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the weight management industry.

The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.

Geographically, North America will be leading the global weight management market in the coming years, due to increasing prevalence of obesity, increase in childhood obesity, strong government support and funding, and change in lifestyle and junk food habits. In addition, increasing membership of health clubs and technological advancement are also driving the growth of the market in North America. Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.


Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/weight-management-market/report-sample

Some of the companies operating in the global weight management market are Amer Sports, Technogym SPA, Weight Watchers International Inc., Ediets.Com Inc., Jenny Craig Inc., Medtronic Inc., Kellogg Company, Brunswick Corporation, Jenny Craig Inc., Atkins Nutritionals Inc., Herbalife Ltd., Apollo Endosurgery Inc., Nutrisystem Inc., Cyber International, Inc., and Johnson & Johnson.

Cardiac Bio-Implant Devices Market Size, Analysis, Growth and Future Scope

The global cardiac bio-implant devices market is witnessing growth due to high incidences of cardiovascular diseases and increasing geriatric population. The massive unexplored cardiac bio-implant devices market in the emerging economies is creating ample opportunities for the growth of the global cardiac bio implant devices market, at a considerable rate in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand for cost effective and efficient cardiac bio-implant devices, thus fuelling the growth of the global cardiac bio-implant devices market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cardiac-bio-implant-devices-market

Cardiovascular disease refers to the disease of heart or blood vessels, which are mainly caused due to blood clot or cholesterol deposit inside an artery. Cardiovascular diseases are of several types including coronary heart disease, rheumatic heart disease, peripheral arterial disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism. Some of the major risk-leading habits towards cardiovascular diseases are high blood pressure, high blood cholesterol, diabetes, smoking and obesity. Moreover, alcohol, lack of exercise and poor nutrition may also cause heart diseases. According to the WHO, cardiovascular diseases are the major cause of all deaths worldwide. The organization also reported that 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all deaths globally. 

Geographically, North America leads the global cardiac bio-implant devices market due to high healthcare expenditure, aging population and high prevalence of cardiovascular diseases. In addition, the technological advancement and high investment by major players for the development of cardiac bio-implant devices are fueling the growth of the cardiac bio-implant devices market in North America. Asia-Pacific is the fastest growing region in the global cardiac bio-implant devices market, driven by improving healthcare infrastructure, growing healthcare expenditure and high prevalence of cardiovascular diseases. Moreover, the Asia-Pacific cardiac bio-implant devices market is growing rapidly due increasing research and development activities and increasing awareness about cardiac bio-implant devices among patients and healthcare providers in emerging economies, such as India and China.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/cardiac-bio-implant-devices-market/report-sample

The key players operating in the global cardiac bio-implant devices market are St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Johnson & Johnson Services Inc., Sorin Group, Abbott and Edwards Lifesciences Corporation.

Clot Management Devices Market - Drivers, Restraints, Opportunities, and Challenges

The global clot management devices market is growing significantly due to large geriatric population and high incidences of cardiovascular diseases, such as stroke and heart attacks. The increasing demand for minimally invasive surgeries and massive unexplored clot management devices market in the emerging economies are creating ample opportunities for the growth of the global clot management devices market. The advanced research and development facilities and new product developments by the major players are supporting the demand for cost-effective and efficient clot management devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/clot-management-devices-market

In the global clot management devices market, a trend of increasing usage of percutaneous procedures for clot management has been observed. Clot management refers to the treatment of patients with blood clots, such as pulmonary embolism, arterial blood clots and deep vein thrombosis. Blood clot or thrombus is formed by platelets and fibrin in blood to stop bleeding from injured blood vessels. However, sometimes a blood clot is formed inside a blood vessel even though when it is not required. This may lead to serious medical consequences, such as deep vein thrombosis and pulmonary embolism. There are several risk-leading factors, such as smoking, certain surgeries, inherited blood clotting diseases, pregnancy, immobility, high cholesterol level and certain heart diseases, which may cause blood clots.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/clot-management-devices-market/report-sample

The key players operating in the global clot management devices market are Applied Medical Resources Corporation, EKOS Corporation (a BTG International group company), St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Volcano Corporation, AngioDynamics, Johnson & Johnson Services Inc., Sorin Group, Bayer AG, Abbott, Stryker and Edwards Lifesciences Corporation.

Single-Use Bioprocessing Systems Market Trends, Size, Growth and Forecast to 2023

Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market.

Explore more or request TOC on “Global Single-Use Bioprocessing Systems Market” at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market

Single-use bioprocessing technology is mainly used in the development and production of biopharmaceuticals. The technology is used throughout the workflow of biopharmaceutical production, starting from buffer and media preparation to bioreactor cultures for vaccines to the storage and shipping of intermediates and bulk biologics. Single-use bio-processing techniques are carried out through several products. Some of the major products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, outer support containers, and single-use mixers. These products reduce cost related to the complex bioproduction procedures, such as cleaning, sterilization, and care of the large bioreactors. 

Europe and North America are the major markets for single-use bioprocessing systems, attributed to the increased life science research and growing demand for biopharmaceuticals. Asia-Pacific market for the single-use bioprocessing systems is growing at a significant rate owing to improving life science infrastructure and increasing investment by several pharmaceutical manufacturing companies for the development of R&D plants in the region. Apart from these regions, Latin America and Middle-East are other important markets of single-use bio-processing systems.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market/report-sample

Country wise, the U.S., followed by Canada, is the largest market for single-use bioprocessing systems in North America. Germany, the U.K., France and Italy are some of the major countries holding significant shares of single-use bio-processing systems market in Europe. In Asia-Pacific, India, Japan, and China are major markets for single-use bio-processing systems; whereas Brazil holds largest market share of single-use bioprocessing systems market in Rest of the World (RoW).

Browse related market research at: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the major players operating in global single-use bioprocessing systems market include Tarpon Biosystems Inc., GE Healthcare, STI Components Inc., Merck & Co Inc., Saint-Gobain Corporation, Sartorius Stedim Biotech SA, PendoTECH, ThermoFisher Scientific Inc., Parker Hannifin Corporation, Pall Corporation, Eppendorf AG, Cellexus Ltd. and Broadley-James Ltd.

Single-Use Bioprocessing Systems Market Size, Drivers, Trends, Challenges & Forecast, 2023

Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market.

Explore more or request TOC on “Global Single-Use Bioprocessing Systems Market” at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market

Single-use bioprocessing technology is mainly used in the development and production of biopharmaceuticals. The technology is used throughout the workflow of biopharmaceutical production, starting from buffer and media preparation to bioreactor cultures for vaccines to the storage and shipping of intermediates and bulk biologics. Single-use bio-processing techniques are carried out through several products. Some of the major products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, outer support containers, and single-use mixers. These products reduce cost related to the complex bioproduction procedures, such as cleaning, sterilization, and care of the large bioreactors. 

Stringent regulations for the implementation of disposable systems and problems associated with the usage of plastic-based disposable products are some of the common factors restraining the growth of the single-use bioprocessing systems market. Moreover, lack of awareness towards innovative applications of disposables in bioproduction is also hindering the growth of the single-use bioprocessing systems market. However, countries, such as China and India are witness a considerable growth during the forecast period due to improving life science research infrastructure.

Request For Table of Content at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market/toc-sample

Some of the major players operating in global single-use bioprocessing systems market include Tarpon Biosystems Inc., GE Healthcare, STI Components Inc., Merck & Co Inc., Saint-Gobain Corporation, Sartorius Stedim Biotech SA, PendoTECH, ThermoFisher Scientific Inc., Parker Hannifin Corporation, Pall Corporation, Eppendorf AG, Cellexus Ltd. and Broadley-James Ltd.

Fluoroscopy and Mobile C-arms Market Size, Analysis, Drivers, Trends, Challenges & Forecast

Growing geriatric population and increasing number of sports injuries worldwide are some of the predominant growth drivers of the fluoroscopy and mobile C arms market. For instance, in the U.S., about 30 million children and teens participate in various types of sports every year. This participation resulted in significant rise in sports-related injuries in the country. Moreover, technological advancement in fluoroscopy and mobile C-arms equipment, improving healthcare infrastructure and rising number of interventional radiology surgeries are also driving the growth of global fluoroscopy and mobile C-arms market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends witnessed in the global fluoroscopy and mobile C-arms market. While the fluoroscopy devices hold larger share in the global fluoroscopy and mobile C-arms market, and the mobile C-arm is the faster growing segment in terms of volume.

Explore Report at: https://www.psmarketresearch.com/market-analysis/fluoroscopy-and-mobile-c-arms-market

Fluoroscopy and mobile C-arms are medical imaging techniques used in variety of diagnostic and therapeutic procedures. Fluoroscopy provides X-ray imaging that is especially useful to examine the internal structure and functions of patient’s body. It is the most commonly used in image-guided surgeries, general radiology and interventional radiology.

The mobile C-arm equipment is also based on X-ray technology and frequently used in vascular surgeries, traumatology, cardiology, and orthopedics. The name “mobile C-arm” is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another. Mobile C-arms are mainly categorized into two types – full size C-arms and mini C-arms. The full size C-arms is the faster growing segment in the global fluoroscopy and mobile C-arm market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/fluoroscopy-and-mobile-c-arms-market/report-sample

By country, Germany, U.K., France, and Italy are some of the major countries holding significant share of fluoroscopy and mobile C-arms market in Europe. In North America, the U.S, followed by Canada, is the largest market for the fluoroscopy and mobile C-arms market. In Asia-Pacific, India, Japan, and China are the major markets for fluoroscopy and mobile C-arms. The Asia-Pacific market is expected to witness the fastest growth, attributed to the increasing healthcare expenditure and presence of large pool of patients. Whereas, Brazil holds largest market share of fluoroscopy and mobile C-arms market in Latin America.

Some of the major players operating in global fluoroscopy and mobile C-arms market include, Ziehm Imaging GmbH, Toshiba Medical Systems Corporation, Siemens Healthcare GmbH, Shimadzu Corporation, Koninklijke Philips N.V., OrthoScan, Inc., Hologic, Inc. and GE Healthcare.

Automated Dispensing Machines Market Analysis, Drivers, Trends, Challenges and Demand, 2023

Increasing number of hospitalization cases and improving healthcare infrastructure around the world are the predominant drivers of the global automated dispensing machines market. In addition, technological advancement in medication dispensing machines and growing demand for automated dispensing systems are also driving the growth of global automated dispensing machines market.  Increasing numbers of mergers and acquisitions is one of the major trends observed in the global automated dispensing machines market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/automated-dispensing-machines-market

Automated dispensing systems are centralized and decentralized medication distribution systems, which provide computer-controlled storage and dispensing of medications. These systems permit nurses to obtain medications for treatment of patients suffering from various health conditions. The automated dispensing systems require user identifiers and their passwords, and electronic devices track the patients for whom prescribed medications are administered and provide usage data to the hospital's financial officer for the patients' bills.

Stringent regulations for the installation of automated dispensing systems and high maintenance and repairing costs are some of the factors restraining the growth of the automated dispensing machines market. Moreover, lack of skilled healthcare professionals for the maintenance of these systems is also hindering the growth of the automated dispensing machines market, especially in the developing markets. However, countries such as China and India are witness a considerable growth in the forecast period due to improving healthcare infrastructure and increasing number of hospitalization cases.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/automated-dispensing-machines-market/report-sample

Some of the major players operating in the global automated dispensing machines market include Yuyama, Aesynt, Talyst, CareFusion, Swisslog, OmniCell, RxMedic Systems, ScriptPro, Rice Lake Weighing Systems, Pearson Medical Technologies, InterMetro Industries, Innovation Associates, ForHealth Technologies, Capsa Solutions, Baxter Healthcare, Avery Weigh-Tronix and Accu-Chart Plus Healthcare Systems.

Disposable Plastic Blood Bag Market Size, Drivers, Growth Rate, Specifications & Forecast

The global disposable plastic blood bag market was valued at $286.5 million in 2014, and it is expected to grow with a CAGR of 9.2% during the period 2015 - 2020. The global disposable plastic blood bag market is growing, due to increasing prevalence of chronic diseases and rising aging population. In addition, rising initiatives undertaken by government associations to boost awareness about blood donations and advanced features of disposable plastic blood bags are also driving the growth of the global disposable plastic blood bag market.

Browse Report with Detailed TOC on “Global Disposable Plastic Blood Bag Market” at: https://www.psmarketresearch.com/market-analysis/disposable-plastic-blood-bag-market

Based on type, the single disposable plastic blood bag market segment is expected to be the largest market and witness fastest growth during the forecast period. Among the end-user segment, hospital had the largest market size in the global disposable plastic blood bag market in 2014.

Increasing prevalence of various chronic diseases, such as cancer and blood disorders, is playing a pivotal role in the growth of disposable plastic blood bag market. Additionally, increased participation of government associations had raised awareness regarding blood donations all over the world. Some of the major associations include the World Health Organization (WHO), International Federation of Red Cross and Red Crescent Societies (IFRC), and American Red Cross. These organizations support blood donation programs and encourage people to donate blood and blood components.

Explore report Sample at: https://www.psmarketresearch.com/market-analysis/disposable-plastic-blood-bag-market/report-sample

The key companies operating in the global disposable plastic blood bag market include Haemonetics Corporation, JMS Co., Ltd., Kawasumi Laboratories, Inc., Grifols International S.A., AdvaCare Pharma, Fresenius SE & Co. KGaA, Terumo Corporation, Macopharma, Genesis BPS, SURU International Pvt. Ltd., Shanghai Transfusion Technology Co., Ltd., Nigale Biomedical Inc. of Sichuan Province Corporation (Nigale), Neomedic Limited, and Shandong Weigao Group Medical Polymer Company Limited.